Frankfurt - Delayed Quote EUR
Rocket Pharmaceuticals, Inc. (9IP1.F)
2.4930
+0.0360
+(1.47%)
At close: June 13 at 9:15:05 AM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.94M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MILITELLO JOHN Officer | Sale at price 6.45 per share. | Direct | 2,301 | May 20, 2025 |
| WILSON MARTIN General Counsel | Sale at price 6.45 per share. | Direct | 3,784 | May 20, 2025 |
| SHAH GAURAV D Chief Executive Officer | Sale at price 6.45 per share. | Direct | 14,523 | May 20, 2025 |
| SCHWARTZ JONATHAN DAVID Officer | Sale at price 6.45 per share. | Direct | 5,163 | May 20, 2025 |
| PATEL KINNARI Chief Operating Officer | Sale at price 6.45 per share. | Direct | 4,944 | May 20, 2025 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 6.53 per share. | Direct | 4,276 | May 16, 2025 |
| WILSON MARTIN General Counsel | Sale at price 6.53 per share. | Direct | 6,175 | May 16, 2025 |
| SHAH GAURAV D Chief Executive Officer | Sale at price 6.53 per share. | Direct | 23,638 | May 16, 2025 |
| SCHWARTZ JONATHAN DAVID Officer | Sale at price 6.53 per share. | Direct | 10,327 | May 16, 2025 |
| PATEL KINNARI Chief Operating Officer | Sale at price 6.53 per share. | Direct | 9,198 | May 16, 2025 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 7.16 per share. | Direct | 5,139 | Apr 22, 2025 |
| SHAH GAURAV D Chief Executive Officer | Purchase at price 5.08 per share. | Direct | 101,600 | Apr 10, 2025 |
| PATEL KINNARI President | Purchase at price 4.70 per share. | Indirect | 99,165 | Apr 9, 2025 |
| ONDREY AARON Chief Financial Officer | Sale at price 5.29 per share. | Direct | 39,647 | Apr 4, 2025 |
| SCHWARTZ JONATHAN DAVID Officer | Sale at price 10.58 - 23.35 per share. | Direct | 223,965 | Feb 25, 2025 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 10.58 per share. | Direct | 28,957 | Feb 21, 2025 |
| WILSON MARTIN General Counsel | Sale at price 10.58 per share. | Direct | 34,089 | Feb 21, 2025 |
| SHAH GAURAV D Chief Executive Officer | Sale at price 10.58 per share. | Direct | 172,486 | Feb 21, 2025 |
| PATEL KINNARI Officer | Sale at price 10.58 per share. | Direct | 64,305 | Feb 21, 2025 |
| MILITELLO JOHN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 11, 2025 |
| WILSON MARTIN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 11, 2025 |
| SHAH GAURAV D Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 11, 2025 |
| SCHWARTZ JONATHAN DAVID Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 11, 2025 |
| PATEL KINNARI Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 11, 2025 |
| ONDREY AARON Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 11, 2025 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 10.38 per share. | Direct | 9,300 | Jan 23, 2025 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 13.05 per share. | Direct | 15,978 | Nov 21, 2024 |
| WILSON MARTIN General Counsel | Sale at price 13.05 per share. | Direct | 15,338 | Nov 21, 2024 |
| SHAH GAURAV D Chief Executive Officer | Sale at price 13.05 per share. | Direct | 144,782 | Nov 21, 2024 |
| PATEL KINNARI Chief Operating Officer | Sale at price 13.05 per share. | Direct | 59,892 | Nov 21, 2024 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 16.62 per share. | Direct | 15,245 | Oct 31, 2024 |
| WHITE MARK ANDREW Officer | Sale at price 16.62 per share. | Direct | 51,205 | Oct 31, 2024 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 18.50 per share. | Direct | 19,688 | Aug 16, 2024 |
| WILSON MARTIN General Counsel | Sale at price 18.50 per share. | Direct | 19,004 | Aug 16, 2024 |
| SHAH GAURAV D Chief Executive Officer | Sale at price 18.50 per share. | Direct | 178,564 | Aug 16, 2024 |
| PATEL KINNARI President | Sale at price 18.50 per share. | Direct | 73,812 | Aug 16, 2024 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 23.02 per share. | Direct | 18,688 | Jul 22, 2024 |
| WHITE MARK ANDREW Officer | Sale at price 20.40 per share. | Direct | 61,715 | Jul 8, 2024 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 23.35 per share. | Direct | 25,195 | May 16, 2024 |
| WILSON MARTIN General Counsel | Sale at price 23.35 per share. | Direct | 24,471 | May 16, 2024 |
| SHAH GAURAV D Chief Executive Officer | Sale at price 23.35 per share. | Direct | 228,596 | May 16, 2024 |
| PATEL KINNARI Chief Operating Officer | Sale at price 23.35 per share. | Direct | 94,474 | May 16, 2024 |
| WILSON MARTIN General Counsel | -- | Direct | -- | May 14, 2024 |
| SHAH GAURAV D Chief Executive Officer | -- | Direct | -- | May 14, 2024 |
| PATEL KINNARI Chief Operating Officer | -- | Direct | -- | May 14, 2024 |
| SOUTHWELL DAVID P Director | Stock Gift at price 0.00 per share. | Indirect | 0 | May 2, 2024 |
| MILITELLO JOHN Officer and Treasurer | Sale at price 22.87 per share. | Direct | 19,051 | Apr 22, 2024 |
| SOUTHWELL DAVID P Director | Sale at price 24.05 - 25.16 per share. | Direct | 1,945,785 | Apr 15, 2024 |
| SOUTHWELL DAVID P Director | Conversion of Exercise of derivative security at price 4.34 per share. | Direct | 432,567 | Apr 15, 2024 |
| WHITE MARK ANDREW Officer | Sale at price 24.64 per share. | Direct | 308,763 | Apr 8, 2024 |
Related Tickers
38I.SG Intellia Therapeutics Inc
7.15
-0.56%
5CV.MU CureVac NV
4.7540
+0.72%
DRMA Dermata Therapeutics, Inc.
0.7123
-2.96%
TERN Terns Pharmaceuticals, Inc.
3.8800
-1.27%
ELEV Elevation Oncology, Inc.
0.3817
+0.39%
SPRY ARS Pharmaceuticals, Inc.
15.39
+6.88%
INAB IN8bio, Inc.
2.2600
-5.04%
HOTH Hoth Therapeutics, Inc.
1.3000
-8.45%
CTXR Citius Pharmaceuticals, Inc.
0.8746
-4.93%
IBRX ImmunityBio, Inc.
3.0700
-3.76%